TM Editors' Note: This article discusses penny stocks and/or microcaps. Such stocks are readily manipulated; do your own careful due diligence. 

The American Pure-Play Multi-State Operator (MSO) Pot Stock Index, while down 1.7% last week, is still +36.6% YTD. Here are the details by constituent and in comparison to the 4 other cannabis and cannabis-related stock categories munKNEE.com tracks.

MSO Pure-Play Pot Stock Index Performance

10 of the 23 stocks in the Index advanced last week of which 6 went up in excess of 5%. 13 declined of which 7 did so by more than 5%. Below is a look at how the major advancers and decliners performed last week with their performances year-to-date in brackets, in descending order:

Major Advancers

1. Harvest Health (HRVSF): +23.4% (+65.7%) to $3.58/share
   • the Pennsylvania Department of Health, Office of Medical Marijuana and AGRiMED (Harvest Health owns the membership interests of AGRiMED, a medical marijuana grower processor facility in Southwestern Pennsylvania) reached a settlement agreement concerning the operation of AGRiMED. 
2. C21 Investments (CXXIF): +14.2% (-14.2%) to $1.21/share
   • no noteworthy news
3. Vireo Health (VREOF): +7.1% (+53.4%) to $2.27/share
   • no noteworthy news
4. Harborside (HBORF): +6.8% (+20.4%) to $1.89/share
   • no noteworthy news
5. Curaleaf (CURLF): +6.4% (+25.3%) to $15.00/share
   • completed the reorganization of its Maryland business which optimizes the company's cultivation, processing and dispensary footprint in Maryland.
6. Verano (VRNOF): +6.3% (N/A) to $19.13/share
   • announced the opening of Zen Leaf West Loop, the first Zen Leaf to open within the City of Chicago.

Major Decliners

1. IM Cannabis (IMCNF): -21.0% (-36.2%) to $4.98/share
   • commenced a marketed offering of its common shares
2. Medicine Man (SHWZ): -17.0% (+53.9%) to $2.34/share
   • no noteworthy news
3. Hempfushion Wellness (CBDHF): -14.7% (N/A) to $0.87/share
   • no noteworthy news
4. Ayr Wellness (AYRWF): -7.8% (+12.6%) to $27.00/share
   • no noteworthy news
5. Jushi (JUSHF): -7.3% (+13.0%) to $6.62/share
   • closed the acquisition of 100% of the equity of Organic Solutions of the Desert, an operating dispensary located in Palm Springs, California, and approximately 78% of the equity of a retail license holder located in Grover Beach, California with the option to acquire the remaining equity in the future.
   • closed the acquisition of a 93,000 sq. ft. facility operated by its wholly-owned subsidiary and Virginia-based pharmaceutical processor, Dalitso LLC, together with approximately nine acres of surrounding land in Prince William County, Virginia, for approximately $22 million.
6. cbdMD (YCBD): -6.8% (+21.7%) to $3.59/share
   • signed an exclusive sponsorship agreement to be the Official CBD Partner of the NOBULL CrossFit Games, which will be held in Madison, Wisconsin from July 27th to August 1st.
7. Columbia Care (CCHWF): -6.2% (+3.3%) to $6.25/share
   • XS Financial Inc., a CAPEX and equipment finance company serving cannabis companies in the United States, announced that it has upsized its total commitment to Columbia Care to $20M.

Pot Stock & Pot-Related Stock Index Performance Comparisons

munKNEE.com tracks the performance of five (5) cannabis categories. Below is a comparison of how each index performed last week (first week of May) and YTD, which we think provides the clearest overview of the cannabis stock sector that is available anywhere:

1. The Conservative Pot Stock Index of 8 constituents tracks the performance of the major consumer and pharmaceutical companies that have bought into marijuana companies.
   • It was +3.1% last week and is +9.7% YTD with an average Beta of 0.96.
2. The Ancillary Pot Stock Index of 17 constituents tracks the performance of companies that provide goods and services to cannabis operators.
   • It was +0.7% last week and has an average Beta of 2.2.
3. The American Pure-Play Multi-State Operators Pot Stock Index of 23 constituents tracks the performance of those multi-state marijuana companies that derive 100% of their revenue from the sector and trade for at least US$1/share.
   • It was -1.7% last week and is +36.6% YTD with an average Beta of 2.69.
4. The Cannabis-Centric BioPharma Stock Index of 13 constituents tracks the stock performance of those clinical-stage bio-pharmaceutical companies involved in the development of drugs using CBD and THC.
   • It was -3.2% and is +4.3% YTD with an average Beta of 2.9.
5. The Canadian Pure-Play Licensed Producers Pot Stock Index of 7 constituents tracks the performance of those Canadian producers that derive 100% of their revenue from the marijuana sector and trade for at least US$1/share:
   • It was -4.9% last week but is +26.0% YTD with an average Beta of 2.11 (see details here).

The above 5 non-tradable indices replicate the performance of a portfolio investing an equal amount of money in each company in the various cannabis categories, with daily rebalancing to maintain equal weight, to serve as benchmarks to measure the performance of individual stocks compared to their respective index. A sum total of 67 cannabis and cannabis-related companies are tracked out of a universe of approximately 200 (i.e. 33.5%) and, on average, they were +1.0% last week and remain +21.1% YTD.

Marijuana ETF Performances

For the record, the performance of the 8 marijuana ETFs (see details here) during the first week of May ranged from -0.2% to -4.2% (-1.8% on average) and have ranged YTD from +16.6% to +49.5% (+32.5% on average).